Cannabinoids and Sickle Cell
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Cannabinoids and Sickle Cell
-
Narrated by:
-
By:
About this listen
During this First Friday conversation, Marijuana Matters talks about Cannabinoids and Sickle Cell Disease (SCD). SCD affects approximately 8% of African Americans, and is characterized by chronic pain and episodic acute pain caused by Vaso occlusive crises, often requiring high doses of opioids for prolonged periods. Evidence is growing that cannabis may help people manage pain from SCD. However, only nine states include sickle cell as an approved health condition for medical marijuana. This conversation was moderated by Marijuana Matters Executive Director Courtney Davis, SCD advocate Demitrious Wyant aka AR the Prophet, and Cannabis Nurse Rebecca Abraham, CEO, and Founder of Acute on Chronic, LLC.
Stay tuned by following Marijuana Matters on these platforms:
- @marijuanamattersdc (IG)
- Marijuana Matters (LinkedIn)
- @socialequitymatters (Facebook)